The content below is part of a paid sponsorship and is not an endorsement by the American Association for Cancer Research^® (AACR), nor does it reflect the views or opinions of the AACR or its members.

From preclinical testing through CDx commercialization – Clarity in every critical moment

Connect each stage of your program with integrated testing capabilities and high‑quality data. From preclinical testing through CDx commercialization, Labcorp helps bring clarity to every critical decision point in your oncology development. Backed by deep scientific expertise, global testing capacity and experience supporting more than 2,000 oncology trials, we’re ready to accelerate your next breakthrough.

Connect with Labcorp at the American Association for Cancer Research® (AACR) Annual Meeting 2026 to meet our scientific innovators and explore tailored strategies to advance your oncology program.

Save the date for our spotlight theater presentation

Clarity at Every Stage: Accelerating and De‑Risking Oncology Development Through Biomarker Strategy
Date: Monday, April 20, 2026
Time: 3:00 p.m. – 4:00 p.m. PT
Location: Spotlight Theater C

Speakers:

Irene Bacalocostantis
Executive Director, Regulatory Affairs, Project Management, Portfolio Management, and Manufacturing, Labcorp

Taylor Jensen
PhD, VP, Head of Science Enterprise Oncology, Labcorp

This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Spotlight Theater are the opinions of the presenter and do not represent the position or the opinion of the American Association for Cancer Research® (AACR) or its members.

About Labcorp

Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.

---